American Society of Health-System Pharmacists. (2012b). Tobacco cessation resource center. [Online].
Retrieved February 27, 2012 from http://www.ashp.org.
Andersen, S. L., & Teicher, M. H. (2009). Desperately driven and no brakes: Developmental stress
exposure and subsequent risk for substance abuse. Neuroscience & Biobehavioral Reviews, 33(4),
516-524.
Anderson, A. L., Reid, M. S., Li, S. H., Holmes, T., Shemanski, L., Slee, A., et al. (2009). Modafinil for
the treatment of cocaine dependence. Drug & Alcohol Dependence, 104(1-2), 133-139.
Anderson, D. J., McGovern, J. P., & Dupont, R. L. (1999). The origins of the Minnesota model of
addiction treatment: A first person account. Journal of Addictive Diseases, 18(1), 107-114.
Anderson, P., Aromaa, S., Rosenbloom, D., & Enos, G. (2008). Screening & brief intervention: Making a
public health difference. Boston: Join Together.
Andrews, G., & Peters, L. (1998). The psychometric properties of the Composite International Diagnostic
Interview. Social Psychiatry & Psychiatric Epidemiology, 33(2), 80-88.
Angermeyer, M. C., & Dietrich, S. (2006). Public beliefs about and attitudes towards people with mental
illness: A review of population studies. Acta Psychiatrica Scandinavica, 113(3), 163-179.
Anglin, M. D., Hser, Y. I., & Grella, C. E. (1997). Drug addiction and treatment careers among clients in
the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 308-
323.
Anthony, E. K., Taylor, S. A., & Raffo, Z. (2011). Early intervention for substance abuse among youth
and young adults with mental health conditions: An exploration of community mental health
practices. Administration & Policy in Mental Health, 38(3), 131-141.
Anthony, J. C., & Helzer, J. E. (1991). Syndromes of drug abuse and dependence. In L. N. Robins & D.
A. Regier (Eds.), Psychiatric disorders in America: The Epidemiologic Catchment Area Study (pp.
116-154). New York: Free Press.
Anthony, J. C., Warner, L. A., & Kessler, R. C. (1994). Comparative epidemiology of dependence on
tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity
Survey. Experimental & Clinical Psychopharmacology, 2(3), 244-268.
Anton, R. (2010). Substance Abuse is a disease of the brain: Focus on alcohol. Journal of Law, Medicine
& Ethics, 38(4), 745-744.
Anton, R. F., & Swift, R. M. (2003). Current pharmacotherapies of alcoholism: A U.S. perspective.
American Journal on Addictions, 12(1), S53-S68.
Anton, R. F., Moak, D. H., Latham, P., Waid, L. R., Myrick, H., Voronin, K., et al. (2005). Naltrexone
combined with either cognitive behavioral or motivational enhancement therapy for alcohol
dependence. Journal of Clinical Psychopharmacology, 25(4), 349-357.
Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999). Naltrexone
and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-
controlled trial. American Journal of Psychiatry, 156(11), 1758-1764.
Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., et al. (2006).
Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE
Study: A randomized controlled trial. JAMA, 295(17), 2003-2017.
Aos, S., Miller, M., & Drake, E. (2006). Evidence-based adult corrections programs: What works and
what does not. Olympia, WA: Washington State Institute for Public Policy.